LearnOptimizeInsightsSignalsInstitutional (Soon)Ask (Soon)Comparisons

Xtrackers USD Corporate Bond Short Duration SRI PAB UCITS ETF 1D

Not currently available · IE00BF8J5974 · Xtrackers

Overview

Xtrackers USD Corporate Bond Short Duration SRI PAB UCITS ETF 1D invests in US-dollar-denominated investment-grade corporate bonds. The distributing share class uses physical replication and charges a TER of 0.16%.

Key facts

Ticker
Not currently available
ISIN
IE00BF8J5974
Provider
Xtrackers
TER (ongoing charge)
0.16%
Benchmark
Not currently available
Fund domicile
IE
UCITS status
UCITS
Asset class
Fixed Income
Category
Not currently available
Distribution
Distributing
Fund currency
Not currently available
Hedged
No

Benchmark & strategy

Benchmark
Not currently available
Index tracked
Not currently available
Replication
Physical

Costs & size

AUM
€115.7M · as of 23 Jul 2026
AUM currency
EUR

Risk & fund structure

Launch date
6 Mar 2018
Replication method
Physical
Share class currency
USD
Currency exposure
Multiple
SFDR
Not currently available

Official Documents

These primary-source links open on the ETF provider’s website.

Data provenance
Source: Not currently available
Source last checked: 25 Jul 2026
Record last updated: 25 Jul 2026
Enrichment status: imported

Continue researching

Related Grovcap guides, rankings and tools to take the next step.

Disclaimer

The information provided by Grovcap is for informational and educational purposes only and does not constitute investment, financial, legal, or tax advice. Investing involves risk, including the possible loss of capital. Always conduct your own research or consult a qualified professional before making investment decisions.

Your responses to quizzes, surveys, and other interactive features may be used in aggregated and anonymized form to improve Grovcap and generate investor insights. We do not sell personally identifiable information to third parties. For more information about how we collect, use, and protect your data, please refer to our Privacy Policy.